Cannabinoid receptor activation and the endocannabinoid system in the gastrointestinal tract

Current Neuropharmacology

Volumn 2, Issue 1, 2004, Pages 91-102

  Coutts, A A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

CB1 receptors; Emesis; Endocannabinoid; Gastrointestinal; Motility; Secretion; SR141716A; Vanilloid

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ION; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOL; CAPSAZEPINE; CISPLATIN; CUPRIC CHLORIDE; DEXANABINOL; DRONABINOL; GRANISETRON; LEVONANTRADOL; METHANANDAMIDE; NABILONE; NALOXONE; ONDANSETRON; PHENTOLAMINE; RIMONABANT; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

CALCIUM CELL LEVEL; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DYSPHORIA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HALLUCINATION; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NAUSEA; NERVE CELL EXCITABILITY; NONHUMAN; PARANOIA; PERISTALSIS; PROTEIN LOCALIZATION; RAT; REVIEW; SMOOTH MUSCLE CONTRACTION; VOMITING; WESTERN BLOTTING;

EID: 3042651005     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570159043476963     Document Type: Review

References (91)

1. Ahluwalia, J., Urban, L., Capogna, M., Bevan, S., Nagy, I. (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688.
2. Akiba, Y., Nakamura, M., Ishii, H. (2001) Immunolocalization of vanilloid receptor-1 (VR-1) in CGRP- positive neurons and interstitial cells of Cajal in the myenteric plexus of the rat gastrointestinal tract. Gastroenterology, 120, 1721.
3. Anavi-Goffer, S., Coutts, A. A. (2003) Cellular distribution of vanilloid VR1 receptor immunoreactivity in the guinea-pig myenteric plexus. Eur. J. Pharmacol., 458, 61-71.
4. Anavi-Goffer, S., McKay, M. G., Ashford, M. L. J., Coutts, A. A. (2002) Vanilloid receptor type 1-immunoreactivity is expressed by intrinsic afferent neurones in the guinea-pig myenteric plexus. Neurosci. Lett., 319, 53-57.
5. Andrews, P. L. R., Sanger, G. J. (2002) Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr. Opin. Pharmacol., 2, 650-656.
6. Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., Shepard, K. V. (1995) Dronabinol as a Treatment for Anorexia Associated with Weight-Loss in Patients with Aids. J. Pain Symptom Manage., 10, 89-97.
7. Begg, M., Molleman, A., Parsons, M. (2002) Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. Eur. J. Pharmacol., 434, 87-94.
8. Blackshaw, L. A., Grundy, D. (1991) 5-Hydroxytryptamine (5-Ht3) Receptor-Mediated Effects on Vagal Mucosal Afferent-Fibers from the Upper Gastrointestinal-Tract of the Anesthetized Ferret. J. Physiol.-London, 435, P64-P64.
9. Blackshaw, L. A., Grundy, D., Scratcherd, T. (1987) Vagal Afferent Discharge from Gastric Mechanoreceptors During Contraction and Relaxation of the Ferret Corpus. J. Auton. Nerv. Syst., 18, 19-24.
10. Boissonade, F. M., Sharkey, K. A., Davison, J. S. (1994) Fos Expression in Ferret Dorsal Vagal Complex after Peripheral Emetic Stimuli. Am. J. Physiol., 266, R1118-R1126.
11. Burdyga, G., Spiller, D., Morris, R., Lal, S., Thompson, D. G., Saeed, S., Dimaline, R., Varro, A., Dockray, G. J. (2002) Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience, 109, 339-347.
12. Casu, M. A., Porcella, A., Ruin, S., Saba, P., Marchese, G., Carai, M. A. M., Reali, R., Gessa, G. L., Pani, L. (2003) Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Eur. J. Pharmacol., 459, 97-105.
13. Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., Gessa, G. L. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci., 63, PL113-PL117.
14. Costa, M., Brookes, S. J. H., Steele, P. A., Gibbins, I., Butcher, E., Kandiah, C. J. (1996) Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience, 75, 949-967.
15. Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., Pagotto, U. (2003) Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity, 27, 289-301.
16. Couceyro, P., Paquet, M., Koylu, E., Kuhar, M. J., Smith, Y. (1998) Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in myenteric plexus neurons of the rat ileum and co-localization with choline acetyltransferase. Synapse, 30, 1-8.
17. Coutts, A. A., Irving, A. J., Mackie, K., Pertwee, R. G., Anavi-Goffer, S. (2002) Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus. J. Comp. Neurol., 448, 410-422.
18. Coutts, A. A., Pertwee, R. G. (1997) Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 1557-1566.
19. Darmani, N. A. (2001) The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Eur. J. Pharmacol., 430, 49-58.
20. Darmani, N. A. (2001c) Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A. Neuropsychopharmacology, 24, 198-203.
21. Darmani, N. A. (2002) The potent emetogenic effects of the endocannabinoid, 2-AG (2- arachidonoylglycerol) are blocked by Delta(9)- tetrahydrocannabinol and other cannabinoids. J. Pharmacol. Exp. Ther., 300, 34-42.
22. Darmani, N, A., Sim-Selley, L. J., Martin, B. R., Janoyan, J. J., Crim, J. L., Parekh, B., Breivogel, G. S. (2003) Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G- protein activation. Eur. J. Pharmacol., 459, 83-95.
23. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agro, A., Di Marzo, V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
24. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
25. Di Carlo, G., Izzo, A. A. (2003) Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin. Investig. Drugs, 12, 39-49.
26. Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., Kunos, G. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822-825.
27. Facer, P., Knowles, C. H., Tam, P. K. H., Ford, A. P., Dyer, N., Baecker, P. A., Anand, P. (2001) Novel capsaicin (VR1) and purinergic (P2X(3)) receptors in Hirschsprung's intestine. J. Pediatr. Surg., 36, 1679-1684.
28. Fan, P. (1995) Cannabinoid Agonists Inhibit the Activation of 5-Ht3 Receptors in Rat Nodose Ganglion Neurons. J. Neurophysiol., 73, 907-910.
29. Feigenbaum, J. J., Richmond, S. A., Weissman, Y., Mechoulam, R. (1989) Inhibition of Cisplatin-Induced Emesis in the Pigeon by a Non- Psychotropic Synthetic Cannabinoid. Eur. J. Pharmacol., 169, 159-165.
30. Ferrari, F., Ottani, A., Giuliani, D. (1999) Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug. Pharmacol. Biochem. Behav., 62, 75-80.
31. Glass, M., Dragunow, M., Faull, R. L. M. (1997) Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77, 299-318.
32. Gomez, R., Navarro, M., Ferrer, B., Trigo, J. M., Bilbao, A., Del Arco, I., Cippitelli, A., Nava, F., Piomelli, D., de Fonseca, F. R. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci., 22, 9612-9617.
33. Gonzalez-Rosales, F., Walsh, D. (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). J. Pain Symptom Manage., 14, 311-314.
34. Gralla, R. J. (1997) Anti-emesis with cancer chemotherapy. Eur. J. Cancer, 33, S63-S67.
35. Green, B. T., Calvin, A., O'Grady, S. M., Brown, D. R. (2003) Kinin-induced anion-dependent secretion in porcine ileum: Characterization and involvement of opioid- and cannabinoid-sensitive enteric neural circuits. J. Pharmacol. Exp. Ther., 305, 733-739.
36. 1 receptor. Proc. Natl. Acad. Sci. USA, 98, 3662-3665.
37. Hasler, W. L. (1999) Serotonin receptor physiology - Relation to emesis. Dig. Dis. Sci., 44, 108S-113S.
38. Hildebrandt, A. L., Kelly-Sullivan, D. M., Black, S. C. (2003) Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur. J. Pharmacol., 462, 125-132.
39. Hornby, P. J. (2001) Central neurocircuitry associated with emesis. Am. J. Med, 111, 106-112.
40. Izzo, A. A., Fezza, F., Capasso, R., Bisogno, T., Pinto, L., Iuvone, T., Esposito, G., Mascolo, N., Di Marzo, V., Capasso, F. (2001a) Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br. J. Pharmacol., 134, 563-570.
41. Izzo, A. A., Mascolo, N., Borrelli, F., Capasso, F. (1999) Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 359, 65-70.
42. Izzo, A. A., Mascolo, N.,Capasso, F. (2001b) The gastrointestinal pharmacology of cannabinoids. Curr. Opin. Pharmacol., 1, 597-603.
43. Izzo, A. A., Mascolo, N., Tonini, M., Capasso, F. (2000) Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum. Br. J. Pharmacol., 129, 984-990.
44. Izzo, A. A., Pinto, L., Borrelli, F., Capasso, R., Mascolo, N., Capasso, F. (2000a) Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br. J. Pharmacol., 129, 1627-1632.
45. Jerman, J. C., Brough, S. J., Davis, J. B., Middlemiss, D. N., Smart, D. (2000) The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1). Br. J. Pharmacol., 129, 73P.
46. Kirchgessner, A. L., Liu, M. T. (1999) Orexin synthesis and response in the gut. Neuron, 24, 941-951.
47. Kirkham, T. C. (2003) Endogenous cannabinoids: a new target in the treatment of obesity. Am. J. Physiol.-Regul. Integr. Comp. Physiol., 284, R343-R344.
48. Kulkarni-Narla, A., Brown, D. R. (2000) Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res., 302, 73-80.
49. Kulkarni-Narla, A., Brown, D. R. (2001) Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons. Neurosci. Lett., 308, 153-156.
50. Landi, M., Croci, T., Rinaldi-Carmona, M., Maffrand, J. P., Le Fur, G., Manara, L. (2002) Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors. Eur. J. Pharmacol., 450, 77-83.
51. Lehmann, A., Blackshaw, L. A., Branden, L., Carlsson, A., Jensen, J., Nygren, E., Smid, S. D. (2002) Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology, 123, 1129-1134.
52. Manara, L., Croci, T., Guagnini, F., Rinaldi-Carmona, M., Maffrand, J. P., Le Fur, G., Mukenge, S., Ferla, G. (2001) Functional assesment of cannabinoid receptors' involvement in human gut motility. FASEB J., 15, A563-A563.
53. Manara, L., Croci, T., Guagnini, F., Rinaldi-Carmona, M., Maffrand, J. P., Le Fur, G., Mukenge, S., Ferla, G. (2002) Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon. Dig. Liver Dis., 34, 262-269.
54. Mancinelli, R., Fabrizi, A., Del Monaco, S., Azzena, G. B., Vargiu, R., Colombo, G. C., Gessa, G. L. (2001) Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. Life Sci., 69, 101-111.
55. Mang, C. F., Erbelding, D., Kilbinger, H. (2001) Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br. J. Pharmacol., 134, 161-167.
56. Mascolo, N., Izzo, A. A., Ligresti, A., Costagliola, A., Pinto, L., Cascio, M. G., Maffia, P., Cecio, A., Capasso, F., Di Marzo, V. (2002) The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J., 16, U131-U151.
57. Matsuda, L. A., Bonner, T. I., Lolait, S. J. (1993) Localization of Cannabinoid Receptor Messenger-RNA in Rat-Brain. J. Comp. Neurol., 327, 535-550.
58. Mattes, R. D., Shaw, L. M., Edlingowens, J., Engelman, K., Elsohly, M. A. (1993) Bypassing the 1st-Pass Effect for the Therapeutic Use of Cannabinoids. Pharmacol. Biochem. Behav., 44, 745-747.
59. McCarthy, L. E., Borison, H. L. (1984) Cisplatin-Induced Vomiting Eliminated by Ablation of the Area Postrema in Cats. Cancer Treatment Reports, 68, 401-404.
60. McVey, D. C., Schmid, P. C., Schmid, H. H. O., Vigna, S. R. (2003) Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther., 304, 713-722.
61. Mechoulam, R., Benshabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., Vogel, Z. (1995) Identification of an Endogenous 2-Monoglyceride, Present in Canine Gut, That Binds to Cannabinoid Receptors. Biochem. Pharmacol., 50, 83-90.
62. Mezey, E., Toth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M.,Szallasi, A. (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. USA, 97, 3655-3660.
63. Miller, A. D., Ruggiero, D. A. (1994) Emetic Reflex Are Revealed by Expression of the Immediate-Early Gene C-Fos in the Cat. J. Neurosci., 14, 871-888.
64. Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., Sugiura, T. (2003) Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. Journal of Neurochemistry, 85, 1374-1381.
65. Parker, L. A., Kemp, S. W. P. (2001) Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: An animal model of anticipatory nausea and vomiting (ANV). Neuroreport, 12, 749-751.
66. Parker, L. A., Mechoulam, R.,Schlievert, C. (2002) Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. Neuroreport, 13, 567-570.
67. Parker, L. A., Mechoulam, R., Schlievert, C., Abbott, L., Fudge, M. L., Burton, P. (2003) Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacology, 166, 156-162.
68. Partosoedarso, E. R., Abrahams, T. P., Scullion, R. T., Moerschbaecher, J. M., Hornby, P. J. (2003) Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. Journal of Physiology., 550, 149-158.
69. Patterson, L. M., Zheng, H. Y., Ward, S. M., Berthoud, H. R. (2003) Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res., 311, 277-287.
70. Pertwee, R. G. (2001) Cannabinoids and the gastrointestinal tract. Gut, 48, 859-867.
71. Pinto, L., Capasso, R., Di Carlo, G., Izzo, A. A. (2002) Endocannabinoids and the gut. Prostaglandins Leukot. Essent. Fatty Acids, 66, 333-341.
72. Pinto, L., Izzo, A. A., Cascio, M. G., Bisogno, T., Hospodar-Scott, K., Brown, D. R., Mascolo, N., Di Marzo, V., Capasso, F. (2002) Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology, 123, 227-234.
73. Pompolo, S., Furness, J. B., Bornstein, J. C., Hendriks, R., Trussell, D. C., Dogiel type II neurons in the guinea-pig small intestine: ultrastructure in relation to other characteristics., in Nerves and the gastrointestinal tract, Singer MV Goebell H, Editors. 1989, MTP Press Ltd.: Lancaster/Boston/The Hague/Dordrecht. p. 57-68.
74. Poonyachoti, S., Kulkarni-Narla, A., Brown, D. R. (2002) Chemical coding of neurons expressing delta- and kappa-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum. Cell Tissue Res., 307, 23-33.
75. Porter, A. C., Sauer, J. M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J. Q., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., Felder, C. C. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
76. Ravinet, T. C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J. P., Soubrie, P. (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol., Regul. Integr. Comp. Physiol., 284, R345-R353.
77. Reynolds, D. J. M., Barber, N. A., Grahame-Smith, D. G., Leslie, R. A. (1991) Cisplatin-Evoked Induction of C-Fos Protein in the Brain-Stem of the Ferret - the Effect of Cervical Vagotomy and the Antiemetic 5-Ht3 Receptor Antagonist Granisetron (Brl-43694). Brain Res., 565, 231-236.
78. Rumessen, J. J., d'Exaerde, A. D., Mignon, S., Bernex, F., Timmermans, J. P., Schiffmann, S. N., Panthier, J. J., Vanderwinden, J. M. (2001) Interstitial cells of Cajal in the striated musculature of the mouse esophagus. Cell Tissue Res., 306, 1-14.
79. Savidge, J., Davis, C., Shah, K., Colley, S., Phillips, E., Ranasinghe, S., Winter, J., Kotsonis, P., Rang, H., McIntyre, P. (2002) Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology, 43, 450-456.
80. Simoneau, II., Hamza, M. S., Mata, H. P., Siegel, E. M., Vanderah, T. W., Porreca, F., Makriyannis, A., Malan, T. P. (2001) The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology, 94, 882-887.
81. Storr, M., Gaffal, E., Saur, D., Schusdziarra, V., Allescher, H. D. (2002) Effect of cannabinoids on neural transmission in rat gastric fundus. Can. J. Physiol. Pharmacol., 80, 67-76.
82. Tominaga, M., Wada, M., Masu, M. (2001) Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. USA, 98, 6951-6956.
83. Tramer, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., McQuay, H. J. (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br. Med. J., 323, 16-21.
84. Tyler, K., Hillard, C. J., Greenwood-Van Meerveld, B. (2000) Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. Eur. J. Pharmacol., 409, 207-211.
85. Ueda, N., Yamamoto, S. (2000) Anandamide amidohydrolase (fatty acid amide hydrolase). Prostaglandins Other Lipid Mediat., 61, 19-28.
86. Van Sickle, M. D., Oland, L. D., Ho, W., Hillard, C. J., Mackie, K., Davison, J. S., Sharkey, K. A. (2001) Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology, 121, 767-774.
87. Van Sickle, M. D., Oland, L. D., Mackie, K., Davison, J. S., Sharkey, K. A. (2003) Delta-9-tetrahydrocannabinol selectively acts on cannabinoid 1(CB1) receptors in specific regions of the dorsal vagal complex to inhibit emesis in the ferret. Am. J. Physiol. Gastrointest. Liver Physiol.,285, G566-G576.
88. Walker, J. M., Krey, J. F., Chu, C. J., Huang, S. M. (2002) Endocannabinoids and related fatty acid derivatives in pain modulation. Chem. Phys. Lipids, 121, 159-172.
89. Yal, W. M., Reese, L. A. (1999) Cannabinoid receptor: Inhibition of ACh release from myenteric plexus of small intestine. Gastroenterology, 116, G4791.
90. Yiangou, Y., Facer, P., Dyer, N. H. C., Chan, C. L. H., Knowles, C., Williams, N. S., Anand, P. (2001) Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet, 357, 1338-1339.
91. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H. H., Sorgard, M., Di Marzo, V., Julius, D., Hogestatt, E. D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.